午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

ChemicalBook >> journal list >> Drug Design, Development and Therapy >>article
Drug Design, Development and Therapy

Drug Design, Development and Therapy

IF: 4.7
Download PDF

Minoxidil and its use in hair disorders: a review.

Published:9 August 2019 DOI: 10.2147/DDDT.S214907 PMID: 31496654
Poonkiat Suchonwanit,?Sasima Thammarucha,?Kanchana Leerunyakul

Abstract

Minoxidil was first introduced as an antihypertensive medication and the discovery of its common adverse event, hypertrichosis, led to the development of a topical formulation for promoting hair growth. To date, topical minoxidil is the mainstay treatment for androgenetic alopecia and is used as an off-label treatment for other hair loss conditions. Despite its widespread application, the exact mechanism of action of minoxidil is still not fully understood. In this article, we aim to review and update current information on the pharmacology, mechanism of action, clinical efficacy, and adverse events of topical minoxidil.

Substances (1)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Minoxidil 38304-91-5 C9H15N5O 783 suppliers $7.00-$941.00

Similar articles

IF:13

Dutasteride: a review of its use in the management of prostate disorders.

Drugs Susan J Keam, Lesley J Scott,etc Published: 1 January 2008
IF:11

Minoxidil: mechanisms of action on hair growth

British Journal of Dermatology A.G. Messenger, J. Rundegren,etc Published: 19 February 2004